Article Details

China grants clearance for Biosyngen's nasopharyngeal carcinoma trial

Retrieved on: 2024-07-17 15:36:30

Tags for this article:

Click the tags to see associated articles and topics

China grants clearance for Biosyngen's nasopharyngeal carcinoma trial. View article details on hiswai:

Excerpt

The gold standard of business intelligence. ... It is engineered to express chimeric receptors to target the EBV antigen on the T-cell surface. BRG01 is ...

Article found on: www.clinicaltrialsarena.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo